Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis-Reference-Cited by-同舟云学术

Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis

Published:2023-07-26 Issue: Volume: Page:1-10
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Azevedo Coutinho Maria C.¹²,Cortez-Dias Nuno¹,Cantinho Guilhermina³,Gonçalves Susana¹,Cunha Nelson¹,Rodrigues Tiago¹,Santos Laura¹,Conceição Isabel²⁴^ORCID,Agostinho João¹,Pinto Fausto J.¹

Affiliation:

1. Department of Cardiology, Santa Maria University Hospital, Lisbon Academic Medical Centre and Cardiovascular Centre of the University of Lisbon, Faculty of Medicine, Lisbon, Portugal

2. Translational Clinical Physiology Unit, Institute of Molecular Medicine, University of Lisbon, Portugal

3. Institute of Nuclear Medicine, Lisbon Academic Medical Centre, University of Lisbon, Lisbon, Portugal

4. Department of Neurosciences, Santa Maria University Hospital, Lisbon Academic Medical Centre, Portugal

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2023.2239987

Reference37 articles.

1. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

2. Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis

3. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

4. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

5. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?;Medicina Clínica;2024-06